GSK plc GSK
NYSE GSK
$48.68 -0.08 (-0.16%)
At close: Oct 29, 2026 · 4:00 PM EDT

Gsk (GSK) Operating Margin (2009 - 2026)

Updated

Gsk (GSK) posted Operating Margin of 23.93% for the quarter ended Sep 30, 2026, down 6.40 percentage points from 30.34% a year earlier but up 18.21 percentage points from the prior quarter.

Analysis

Gsk (GSK) Operating Margin (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Operating Margin at Gsk was 22.28%, down 1.21 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at 24.28%, up 11.47 percentage points from the prior year.

  • Annual Operating Margin shows a five-year change of -0.27 percentage points (years ended Dec 2020 to Dec 2025).
  • In prior years, Gsk's Operating Margin was 12.82% in the year ended Dec 31, 2024 (-9.42 pp), 22.24% in the year ended Dec 31, 2023 (+0.30 pp), 21.94% in the year ended Dec 31, 2022 (+4.30 pp) and 17.64% in the year ended Dec 31, 2021 (-6.91 pp).
  • Quarterly Operating Margin has run from a low of 2.36% in the quarter ended Sep 30, 2024 to a high of 31.89% in the quarter ended Mar 31, 2022 over five years.
  • On a year-over-year basis, Operating Margin increased in six of the last eight quarters, with an average year-over-year change of +4.18 percentage points.
  • The strongest year-over-year quarter for Operating Margin in the past five years was the quarter ended Sep 30, 2025, with a gain of 27.98 percentage points; the weakest was the quarter ended Sep 30, 2024, with a drop of 21.56 percentage points.
  • According to Business Quant data, Operating Margin for the three prior quarters was 5.72% (quarter ended Jun 30, 2026), 30.06% (quarter ended Mar 31, 2026) and 24.28% (quarter ended Dec 31, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,264.17 Bn 1,237.79 Bn 20.46 Bn 52.42%
2 Johnson & Johnson 660.04 Bn 579.90 Bn 17.30 Bn 24.35%
3 AbbVie 521.06 Bn 494.17 Bn 12.70 Bn 37.86%
4 Merck 370.60 Bn 370.60 Bn - -
5 Novartis Ag 311.97 Bn 285.20 Bn - -
6 Astrazeneca 288.69 Bn 262.37 Bn 12.86 Bn 20.57%
7 Amgen 252.29 Bn 207.69 Bn 7.24 Bn 34.95%
8 Gilead Sciences 213.47 Bn 213.47 Bn - -
9 Pfizer 173.68 Bn 120.32 Bn 10.94 Bn 28.37%
10 Gsk 100.27 Bn 83.11 Bn 8.73 Bn 23.93%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 23.93%
Jun 30, 2026 5.72%
Mar 31, 2026 30.06%
Dec 31, 2025 24.28%
Sep 30, 2025 30.34%
Jun 30, 2025 25.33%
Mar 31, 2025 29.48%
Dec 31, 2024 8.57%
Sep 30, 2024 2.36%
Jun 30, 2024 20.88%
Mar 31, 2024 20.24%
Dec 31, 2023 7.12%
Sep 30, 2023 23.92%
Jun 30, 2023 29.83%
Mar 31, 2023 29.95%
Dec 31, 2022 25.33%
Sep 30, 2022 15.21%
Jun 30, 2022 15.60%
Mar 31, 2022 31.89%
Dec 31, 2021 6.95%
API Access

Gsk Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=GSK&period=max&api_key=YOUR_API_KEY